TABLE 1.
Demographic and clinical features at the time of presentation of children with bacteremia due to either ESBL-producing or ESBL-nonproducing E. coli or K. pneumoniae
Characteristic | ESBL group (n = 49) | Non-ESBL group (n = 93) | P valuea |
---|---|---|---|
Sex (no. of males: no. of females) | 27:22 | 54:39 | 0.79 |
Mean ± standard deviation age (yr) | 4.58 ± 5.02 | 7.17 ± 5.97 | 0.01 |
Status or underlying disease (no. of episodes) | |||
Hematological malignancy | 22 | 44 | 0.77 |
Solid tumor | 9 | 10 | 0.21 |
Steroid user | 1 | 5 | 0.66 |
Preterm | 6 | 6 | 0.24 |
Neonate | 3 | 4 | 0.45 |
Othersb | 8 | 18 | 0.66 |
Nonec | 0 | 6 | 0.09 |
Focus of infection (no. [%] of episodes) | 13 (27) | 39 (42) | 0.07 |
Pneumonia | 6 | 7 | 0.35 |
Peritonitis | 1 | 5 | 0.66 |
Urinary tract infection | 3 | 8 | 0.75 |
Abscess | 1 | 4 | 0.72 |
Cellulitis | 0 | 5 | 0.72 |
Ascending cholangitis | 2 | 6 | 0.72 |
Meningitis/acute otitis media/septic knee/typhlitis | 0 | 1/1/1/1 | |
Presenting condition at sepsis onset or presentationd | |||
Shock | 6/42 | 8/87 | 0.384 |
Hypothermia | 2/42 | 2/87 | 0.596 |
Renal insufficiency | 1/42 | 5/86 | 0.663 |
Hepatic dysfunction | 9/41 | 25/86 | 0.397 |
Neurological dysfunction | 1/41 | 1/87 | 0.540 |
Respiratory difficulty in case of pneumonia | 0/6 | 0/7 |
Association was evaluated by Pearson's χ2 test or Fisher's exact test for all parameters except age, which was compared by the Student t test.
Others include biliary atresia (n = 8 episodes), chronic renal diseases (n = 3); chronic encephalopathy (n = 3); congenital neuromuscular diseases (n = 2); bronchopulmonary dysplasia (n = 2); chronic hepatitis (n = 2); failure to thrive (n = 2), and one episode each of congenital heart disease, Kasabach-Meritt syndrome, intestinal pseudo-obstruction with central venous catheter, and toxic shock syndrome.
These six patients were associated with urinary tract infections (4 cases) or acute appendicitis (2 cases).
The values represent the number of episodes with the indicated condition/total number of patients evaluated.